Abstract
Objective Evaluate potassium for reducing joint pain in rheumatoid arthritis (RA)
Methods 172 consenting patients with painful RA (median duration 6.5 years) on standard treatment with conventional DMARD (median duration 22 months) were randomized into an assessor blind multi-arm study (80% power) of 16 weeks duration; potassium rich vegetarian diet (Arm A) and with additional potassium food supplement (Arm B) or regular diet (control, Arm C). Efficacy (American College Rheumatology), safety and food consumption (three-day retrospective recall) were assessed at four-weekly intervals. Potassium and diet were analyzed according to India recommendations. Standard statistic tests were used (significance at p <0.05, two sided). Study arms were matched at baseline. Background medication remained stable except reduced analgesics.
Results 155 patients (90.1%) completed study. Patients improved several measures with good safety and tolerance (potassium). Adverse events were mild; none caused withdrawal. The mean change in pain visual analogue scale/VAS (-2.23, 95% confidence interval -2.99 to -1.48) at week 16 (primary efficacy) in Arm B was significantly superior by study arms as per protocol analysis; better improvement in function and quality of life. High potassium intake (≥ 5 gm daily) showed significant association with low pain (< 4ms VAS) on study completion; Odds Ratio 2.5 univariate analysis, Likelihood Ratio 2.9 stepwise forward logistic regression adjusted for several clinical and diet variables. Compliance and food record were important concern.
Conclusion High potassium intake using diet and a novel food supplement reduced joint pain in RA and seemed a safe adjunct. Further validation is required.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
CTRI/2022/03/040726
Funding Statement
This study did not receive any funding from any external or commercial source. Non-commercial investigator initiated study and partly funded by Arthritis Research Care Foundation - Center for Rheumatic Diseases, Pune, India.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee, Arthritis Research Care Foundation Center for Rheumatic Diseases, Pune, India. The approval letter dated 04 Feb 2014 is enclosed as a supporting document
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding and Support: Non-commercial investigator initiated study and partly funded by Arthritis Research Care Foundation - Center for Rheumatic Diseases, Pune, India. No funds or material help received from any commercial source. Subsequent to the completion of the study, Dr Toktam Kianifard (principal investigator), Ms Manjit Saluja and Dr Arvind Chopra applied and were granted a patent (India) for the novel potassium food supplement that was used in the study.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
